Eden Research (LON:EDEN) Stock Price Down 13.2% – What’s Next?

Eden Research plc (LON:EDEN)’s stock price was down 13.2% on Monday . The stock traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares changed hands during trading, an increase of 133% from the average daily volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Trading Up 3.5 %

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock’s 50-day simple moving average is GBX 3.36 and its two-hundred day simple moving average is GBX 3.71. The firm has a market capitalization of £14.35 million, a P/E ratio of -9.42 and a beta of 0.92.

Insider Transactions at Eden Research

In other news, insider Alexander John Abrey bought 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($28,076.35). Also, insider Sean M. Smith purchased 426,986 shares of the company’s stock in a transaction that occurred on Tuesday, April 1st. The shares were purchased at an average cost of GBX 234 ($3.04) per share, with a total value of £999,147.24 ($1,297,425.32). Over the last quarter, insiders have purchased 1,391,473 shares of company stock valued at $103,604,725. 14.02% of the stock is currently owned by corporate insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.